发明名称 |
Improved organ protection, preservation and recovery |
摘要 |
600011 Disclosed is a the use of : (i) a potassium channel opener or agonist or adenosine receptor agonist for example Adenosine; and (ii) a local anaesthetic for example the Class 1 B antiarrhythmic agent Lignocaine; and (iii) an opioid for example [D-Pen2,5]enkaphalin (DPDPE), in the preparation of a medicament for reducing damage to a postconditioned cell, tissue or organ following ischemia or trauma or during ischemia or reperfusion. Postconditioning is a particular therapy where there is rapid intermittent interruptions of blood flow in the early phase of reperfusion. |
申请公布号 |
NZ600011(A) |
申请公布日期 |
2014.01.31 |
申请号 |
NZ20080600011 |
申请日期 |
2008.07.25 |
申请人 |
HIBERNATION THERAPEUTICS LIMITED |
发明人 |
DOBSON GEOFFREY PHILLIP |
分类号 |
A01N1/02;A61K31/167;A61K31/4406;A61K31/549;A61P41/00 |
主分类号 |
A01N1/02 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|